Skip to main navigation Skip to search Skip to main content

AALL2121, a phase 2 study of SNDX-5613 in combination with chemotherapy

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date11/1/23 → 10/31/26

Funding

  • Public Health Institute: $1.00